go to contents go to 1depth menu
Aiming to be a global drug maker

RESEARCH AREA

CJ HealthCare Corp. studies various fields.

ONCOLOGY PROJECT CJ-15314 CJ-14199 K-CAB Tab.
NCE Etc. Immuno-
Oncology
Rheumatoid
Arthritis
Non-
alcoholic steatohepatitis
Gastro
esophageal reflux disease

CJ HealthCare Corp. is expanding its pipeline by focusing on digestive disorders, anti-cancer, and immune diseases that have high unmet needs in the market.
Based on its experience and know-how in the development of fixed dose combination IMDs, CJ HealthCare Corp. is developing various new drugs, such as the gastroesophageal reflux disease treatment ‘K-CAB Tab.’. CJ HealthCare Corp. is accelerating the development of promising new drugs and expanding its R&D network by continuously carrying out "open innovation" with excellent R&D venture companies in Korea, Japan, the U.S. and Europe.